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To generate BJNhem20-OCIAD1-Tet-ON cell line, we transfected
BJNhem20 with pCAG-Tet-On (pCAG-rtTAOn) and pTRE-Tight-OCIAD1
by microporation at 1100 V, 30 ms pulse width and 1 pulse number
(see Fig. 1A). A stable hESC line was generated after subjecting these
transfected cells to hygromycin and geneticin selection for ten days.
The pTRE-Tight-OCIAD1 construct was generated by cloning OCIAD1
Open Reading Frame amplicon from amino acids 1 to 245 between
EcoRI and NotI sites using appropriate primers. Induction of OCIAD1 ex-
pression was done using doxycyline (300 ng/ml).
Expression of pluripotent stem cell markers OCT4, SSEA4 and TRA1–
81 has been shown by immunostaining andRT-qPCR analyses. Early dif-
ferentiation of BJNhem20-OCIAD1-Tet-Onwas demonstrated by immu-
nostaining for N-cadherin.
Materials and methods
Cell culture
hESC line BJNhem20 was derived from discarded Grade III embryos
and tested for pluripotency (Inamdar et al., 2009). This cell line has
been cultured continuously for over 200 passages without acquiring
any karyotypic abnormality (Venu et al., 2010). The cell line was includ-
ed in the analysis of genetic stability in the International Stem Cell Initia-
tive project (ISCI2, 2011). Cultures of BJNhem20 and the transgenic line
BJNhem20-OCIAD1-Tet-Onweremaintained onmouse embryonicﬁbro-
blast feeder layers in hESC medium composed of KnockOut Dulbecco's
modiﬁed Eagle medium (KO-DMEM-Life Technologies; cat no. 10829-
018) supplemented with 20% KnockOut Serum replacement (KOSR-Life
Technologies; cat no. 10828-028), 1% GlutaMAX (Life Technologies; cat
no. 35050-061), 1% non-essential amino acids (MEM-NEAA-Lifethe CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
Fig. 1. Expression and karyotype analysis of BJNhem20-OCIAD1-Tet-On line:-. (A) Schematic representation of pTRE-Tight-OCIAD1 plasmid and strategy for generation of OCIAD1
inducible overexpression line. (B) Validation of OCIAD1 overexpression in BJNhem20-OCIAD1-Tet-On cell line grown on Matrigel and induced with Doxycycline, by immunostaining
with OCIAD1 antibody. (C–D) Quantitative real-time PCR (C) and Western blot analysis (D) showing OCIAD1 overexpression upon Doxycycline induction. Graphs represent data from
at least three biological replicates. (E) Pluripotency marker expression in BJNhem20-OCIAD1-Tet-On by immunostaining for OCT4, SSEA4 and TRA1–81. (F) Analysis of transcript levels
of pluripotency marker genes by quantitative polymerase chain reaction (qPCR). (G) Tight regulation on pluripotency regulators expression upon Doxycycline induction of OCIAD1
analyzed by Western blot for Oct4 and Nanog. (H) Analysis of early differentiation (day 3.5) to mesodermal lineage upon Doxycycline induction, by immunostaining with N-cadherin
antibody.
247D.K. Shetty et al. / Stem Cell Research 16 (2016) 246–248Technologies; cat no. 11140-050), 0.1% β-mercaptoethanol (Life Tech-
nologies; cat no. 21985-023) and 8 ng/ml human recombinant basic
ﬁbroblast growth factor (human bFGF-Sigma Aldrich Pvt. Ltd.; cat no.
F-0291). These cells were routinely passaged by mechanical cutting of
undifferentiated colonies.Microporation of hESCs to generate BJNhem20-OCIAD1-Tet-On cell line
The plasmids pCAG-Tet-On (pCAG-rtTAOn) and vector pTRE-Tight
were a kind gift from Norio Nakatsuji (Kyoto University, Japan). We
generated pTRE-Tight-OCIAD1 construct by cloning OCIAD1 Open
Reading Frame amplicon from amino acids 1 to 245 between EcoRI
and NotI sites using appropriate primers. For microporation,
BJNhem20 cells were grown on Matrigel (Becton Dickinson; cat no.
354277) coated dishes till they were 70% conﬂuent. The cells were
trypsinized with 1× TrypLE (Life Technologies; cat no. 12605-010)
at 37 °C for 4 min. The cells were pelleted by centrifugation at
1000 rpm for 2 min and washed with phosphate buffered saline
and enumerated. 0.5 million cells were resuspended in 10 μl of R
buffer and 5 μg of both the plasmids was mixed and the cells were
transfected in a microporator (Neon Microporation Kit-Life Technol-
ogies; cat no. MPK1096). Microporation conditions used were
1100 V, 30 ms and 1 pulse according to the manufacturer's instruc-
tions. The cells were then directly seeded onto Matrigel-coated
dishes with mTESR media (Stem Cell Technologies; cat no. 05850)
supplemented with ROCK inhibitor (10 μM Y-27632, Sigma Aldrich
Pvt. Ltd.; cat no. Y0503) to aid the survival of single cells. mTESR me-
dium without ROCK inhibitor was used after 12–16 h when the cells
adhered. 48 h after transfection, hygromycin (10 μg/ml SigmaAldrich Pvt. Ltd.; cat no.H-3274) and geneticin (100 μg/ml Life Tech-
nologies; cat. no. 11811-031) were added to the transfected culture
and selection was continued for 10 days. Hygromycin and geneticin
resistant individual clones were manually picked and passaged.
BJNhem20-OCIAD1-Tet-On cells were subsequently cultured in
both feeder free conditions on Matrigel in the presence of mTESR
medium and on feeders with regular hESC medium.Induction of OCIAD1 expression with Doxycycline
Wild type and OCIAD1-Tet-On cells were plated at a density of
30% conﬂuence on Matrigel-coated plates in mTESR medium. After
24 h of seeding once the colonies have attached 300 ng/ml of Doxy-
cycline (Sigma Aldrich Pvt. Ltd., cat no. D9891) was added to the me-
dium and cells were cultured for 72 h replenishing with fresh
Doxycycline containing medium every 24 h. To test for induction of
OCIAD1 expression, control and test cell lines were harvested after
48 h for RNA extraction and 72 h for protein extraction or ﬁxed for
immunostaining.Differentiation of embryonic stem cells
Differentiation of embryonic stem cells was carried out as de-
scribed before (Evseenko et al., 2010). Brieﬂy, colonies grown on
Matrigel were mechanically cut and re-passaged onto Matrigel-
coated dishes and grown in mTESR medium for 2 days. The medium
was then changed to hematopoietic differentiation basal media
(Stemline II) with growth factors BMP4, Activin A, VEGF and bFGF
248 D.K. Shetty et al. / Stem Cell Research 16 (2016) 246–248(all Sigma Aldrich Pvt. Ltd) for 3.5 days. Cells were then ﬁxed and im-
munostained as follows.
Immunostaining
hESC and hEBs were ﬁxed in 2% paraformaldehyde (in PBS), perme-
abilized with Triton-X 100 (0.1% for cells and 0.3% for EBs) and then
blocked with 4% FBS for 1 h at RT (room temperature). Post blocking,
cells were incubated with the appropriate primary antibodies overnight
at 4 °C, then were washed with PBS at RT and incubated with secondary
antibody conjugated to either Alexa Fluor 488 or 568 for 1 h at RT (Dilu-
tion 1:400 Invitrogen). The cells were washed and stained using DAPI
(1:500 in M1 buffer Invitrogen) to visualize the nuclei. The images
were acquired using an epiﬂuorescence microscope (IX-81 microscope
system (Olympus)) ﬁtted with a cooled CCD camera (CoolSnap, Roper
Scientiﬁc). Primary antibodies used were against OCIAD1 (Abcam; cat
no., Ab91574), Oct4 (BD Biosciences BD 611203), and TRA1–81 and
SSEA4monoclonal antibodies were a kind gift from Peter Andrews (Uni-
versity of Shefﬁeld, UK), N-cadherin (BDBiosciences; cat no. BD610921).
RNA isolation/cDNA synthesis and quantitative PCR
Total RNA was extracted from cells by TRIzol reagent (Life Technol-
ogies; cat no. 15596-026) following the manufacturer's instructions.
2 μg of DNase treated RNA was converted to cDNA by performing re-
verse transcription using Superscript II (Life Technologies; cat no.
18064-014). Quantitative real time PCRwas performed using EvaGreen
Master Mix (Biorad). Primer sequences used for cDNA ampliﬁcation
(5′–3′) were as follows:Primer nameo
o
so
so
n
n
ga
ga
OSequencect4_F GAAGGTATTCAGCCAAACGAC
ct4_R GTTACAGAACCACACTCGGA
x2_F AGTCTCCAAGCGACGAAAAA
x2_R GCAAGAAGCCTCTCCTTGAA
anog_F TGCAAATGTCTTCTGCTGAGAT
anog_R GTTCAGGATGTTGGAGAGTTC
pdh_F GTCCATGCCATCACTGCCA
pdh_R TTACTCCTTGGAGCCATG
CIAD1_F AGGAACCATGGATGGGAGGGCTGACTTTC
CIAD1_R CATTACTCGAGCTCATCCCAAGTATCTCCOWestern blot
For Western blot analysis, cells were pelleted, washed with 1× PBS,
lysed in lysis buffer for 4 h at 4 °C and clariﬁed by centrifugation at
10,000 rpm for 20 min at 4 °C. Total protein was estimated using Brad-
ford reagent and 40 μg of lysate was loaded on a 12% SDS-PAGE gel. The
gel was electro-blotted onto Nitrocellulose membrane (PALL corpora-
tion, USA) and incubated with OCIAD1 (Abcam; cat no., Ab91574),
Oct3/4 (BD Biosciences; cat no. BD 611203), Nanog (Santacruz; cat no.
sc-30328) and β tubulin (DSHB — Developmental Studies Hybridoma
Bank; E7) primary antibodies at 4 °C (overnight), washed, then probed
with appropriate HRP-conjugated secondary antibodies (Bangalore
Genei) for 1 h at RT and developed using ECL chemiluminescence kit
(Thermo Scientiﬁc, Rockford, IL, US).
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